Skip to main content

Table 1 Schedule of study flow and assessments

From: Effect of low-dose amitriptyline on reducing pain in clinical knee osteoarthritis compared to benztropine: study protocol of a randomised, double blind, placebo-controlled trial

 

Enrolment

Baseline

2 weeks

6 weeks

12 weeks

ENROLMENT:

 Eligibility screen

x

    

 Informed consent

x

    

 Clinical assessment

 

x

   

 Randomisation

 

x

   

INTERVENTION:

 Amitriptyline, 25 mg nocte

 

Alternate

Nightly

Nightly

Nightly

 Benztropine, 1 mg, nocte

 

Alternate

Nightly

Nightly

Nightly

ASSESSMENTS

 Primary and secondary outcomes

  WOMAC (pain, stiffness, function, total)

 

x

  

x

 Other measures of knee pain

  Pain severity (NRS, 0–10)

 

x

x

x

x

  Pain severity (VAS, 100 mm), pain diagram

 

x

  

x

  PainDETECT

 

x

  

x

 Functional status and severity

  ACR functional class I, II or III

 

x

  

x

  Investigator assessed global assessment of OA status (Likert, 0 very well–4 very poor)

 

x

  

x

  General health status (AQOL-8D)

 

x

  

x

  Leg muscle strength (in triplicate)

 

x

  

x

  Xray – KL score, osteophytes, JSN

 

x

   

 Other measures of response

  Pain acceptability (48 h)

 

x

  

x

  Patient global impression of change (Likert, 0–7)

  

x

x

x

 Other measures

  Inclusion criteria: pain & 1 of age > 50, stiff <30mins, Crepitus, osteophytes and KOA

 

x

   

  Age, height, weight, bp, smoking

 

x

   

  Medical conditions

 

x

  

x

  Education (category), Employment current status, type of work (manual, office, NA)

 

x

   

  Medications – analgesics, NSAID, opioid

 

x

  

x

  Fear of movement (TSK)

 

x

  

x

  Mood disorder (HADS)

 

x

  

x

  Physical activity (IPAQ, 7 days)

 

x

  

x

  Sleep quality and disturbance (PSQI)

 

x

  

x

 Treatment and safety issues

  Medications – analgesics, NSAID, opioid

 

x

  

x

  Treatment belief: study drug or placebo

    

x

  Rating of medication and side effects (Scale, excellent, good, fair, poor, unacceptable)

    

x

  UKU

 

x

x

x

x

  Adverse events

  

x

x

x

  Adherence, pill count

    

x

  1. WOMAC Western Ontario and McMaster Arthritis Index. NRS Numerical rating scale VAS visual analogue scale, AQOL-8D Assessment of quality of life. TSK Tampa Scale of Kinesiophobia HADS Hospital anxiety and depression scale IPAQ International physical activity questionnaire PSQI Pittsburgh sleep quality index UKU: UKU Side effect rating scale for psychotropic drugs